InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,319.31
(
2.30%
)
US TECH 100
18,004.00
(
3.53%
)
Dow Jones
39,446.49
(
1.76%
)
Brent Oil
78.85
(
0.14%
)
Bitcoin
61,535.16
(
-0.33%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ECole

Send PM Follow Ignore
Followers 21
Posts 1331
Boards Moderated 1
Alias Born 07/02/2013

ECole

Re: None

Friday, 07/12/2013 10:10:30 AM

Friday, July 12, 2013 10:10:30 AM

Post# of 80490
Ariad specializes in discovery and developing best-in-class kinase inhibitors for various cancers

The first approval was achieved late last year that is the drug is called Iclusig and the drug is for CML. It is a form of leukemia. The second candidate is called AP26113 and that drug in for lung cancer.

Read here
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up